Sharp Colin P, Norja Päivi, Anthony Iain, Bell Jeanne E, Simmonds Peter
Centre for Infectious Diseases, Neuropathology Unit, University of Edinburgh, United Kingdom.
J Infect Dis. 2009 Feb 1;199(3):398-404. doi: 10.1086/596062.
Infection with the human polyomaviruses BK (BKV) and JC (JCV) is almost ubiquitous, asymptomatic, and lifelong. However, reactivation during immunosuppression, associated with mutations in the transcriptional control region (TCR) that up-regulates viral replication, can cause life-threatening disease. In this study, we investigated whether the recently discovered WU and KI polyomaviruses (WUPyV and KIPyV) and Merkel cell polyomavirus (MCPyV) could, like BKV and JCV, persist, mutate, and reactivate in immunodeficient subjects.
Autopsy samples of lymphoid tissue from 42 AIDS-immunosuppressed subjects and 55 control samples were screened by polymerase chain reaction for all 5 polyomaviruses. TCR sequences from KIPyV and WUPyV recovered from both immunosuppressed and nonimmunosuppressed subjects were compared.
Combined polyomavirus detection frequencies were much higher for the immunosuppressed group, compared with the nonimmunosuppressed group (35.7% vs. 3.6%), with viral loads in lymphoid tissues ranging from < or = 8.4 x 10(5) to > 1.5 x 10(5) viral genome copies per 10(6) cells. MCPyV was recovered from only 1 HIV-negative study subject. TCR sequences from reactivated WUPyV and KIPyV variants showed a number of point mutations and insertions that were absent in viruses recovered from respiratory tract specimens obtained from nonimmunosuppressed subjects.
KIPyV and WUPyV show reactivation frequencies comparable to those of BKV and JCV during immunosuppression. TCR changes that potentially lead to transcriptional dysregulation may have pathogenic consequences equivalent in severity to those observed for JCV and BKV.
人多瘤病毒BK(BKV)和JC(JCV)感染几乎普遍存在、无症状且持续终生。然而,免疫抑制期间的病毒再激活,与上调病毒复制的转录控制区(TCR)突变相关,可导致危及生命的疾病。在本研究中,我们调查了最近发现的WU和KI多瘤病毒(WUPyV和KIPyV)以及默克尔细胞多瘤病毒(MCPyV)是否能像BKV和JCV一样,在免疫缺陷受试者体内持续存在、发生突变并再激活。
通过聚合酶链反应对42例艾滋病免疫抑制受试者的淋巴组织尸检样本和55例对照样本进行所有5种多瘤病毒的筛查。比较从免疫抑制和非免疫抑制受试者中回收的KIPyV和WUPyV的TCR序列。
与非免疫抑制组相比,免疫抑制组的多瘤病毒联合检测频率要高得多(35.7%对3.6%),淋巴组织中的病毒载量范围为每10^6个细胞<或 = 8.4×10^5至>1.5×10^5个病毒基因组拷贝。仅从1名HIV阴性研究受试者中回收了MCPyV。再激活的WUPyV和KIPyV变体的TCR序列显示出一些点突变和插入,而从非免疫抑制受试者的呼吸道标本中回收的病毒中不存在这些突变和插入。
KIPyV和WUPyV在免疫抑制期间的再激活频率与BKV和JCV相当。可能导致转录失调的TCR变化可能具有与JCV和BKV所观察到的相当严重程度的致病后果。